These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21389124)

  • 1. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
    Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
    J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
    Cote PJ; Butler SD; George AL; Fairman J; Gerin JL; Tennant BC; Menne S
    J Med Virol; 2009 Oct; 81(10):1760-72. PubMed ID: 19697409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
    Lu M; Hilken G; Kruppenbacher J; Kemper T; Schirmbeck R; Reimann J; Roggendorf M
    J Virol; 1999 Jan; 73(1):281-9. PubMed ID: 9847331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
    Luxembourg A; Hannaman D; Wills K; Bernard R; Tennant BC; Menne S; Cote PJ
    Vaccine; 2008 Jul; 26(32):4025-33. PubMed ID: 18556096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
    Lu M; Isogawa M; Xu Y; Hilken G
    J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
    Lu M; Roggendorf M
    Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
    Lu M; Klaes R; Menne S; Gerlich W; Stahl B; Dienes HP; Drebber U; Roggendorf M
    J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
    Siegel F; Lu M; Roggendorf M
    J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
    Kosinska AD; Johrden L; Zhang E; Fiedler M; Mayer A; Wildner O; Lu M; Roggendorf M
    J Virol; 2012 Sep; 86(17):9297-310. PubMed ID: 22718818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.
    Kosinska AD; Zhang E; Johrden L; Liu J; Seiz PL; Zhang X; Ma Z; Kemper T; Fiedler M; Glebe D; Wildner O; Dittmer U; Lu M; Roggendorf M
    PLoS Pathog; 2013; 9(6):e1003391. PubMed ID: 23785279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
    J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.
    Menne S; Maschke J; Tolle TK; Lu M; Roggendorf M
    J Virol; 1997 Jan; 71(1):65-74. PubMed ID: 8985324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.
    Glebe D; Lorenz H; Gerlich WH; Butler SD; Tochkov IA; Tennant BC; Cote P; Menne S
    J Virol; 2009 Feb; 83(4):1579-91. PubMed ID: 19052077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids.
    Chen H; Wen B; Deng Y; Wang W; Yin X; Guan J; Ruan L; Tan W
    Clin Vaccine Immunol; 2011 Nov; 18(11):1789-95. PubMed ID: 21900535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
    Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
    Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
    J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
    Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
    PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.